Ilika publishes 2025 Annual Report, advancing Goliath and Stereax

IKA

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology, has given formal notice that the Company’s Annual General Meeting will be held on Tuesday, 23 September 2025 at 2.00 pm (BST) at the offices of Eversheds Sutherland LLP, One Wood Street, London EC2V 7WS.

If you wish to attend the AGM in your capacity as a shareholder, please bring proof of shareholding or, if shares are held through a nominee account, a letter of representation, to facilitate your entry to the Meeting. If you are not planning to attend the meeting and would like someone else to vote for you at the meeting (or any adjournment of the meeting), please complete the form of proxy, which can be accessed using the following link www.investorcentre.co.uk/eproxy

Shareholders are encouraged to appoint the Chairman of the Meeting as their proxy with their voting instructions. Please vote online at www.investorcentre.co.uk/eproxy and enter the Control Number, your Shareholder Reference Number (SRN), and PIN as shown on the Proxy Form.

To be valid, proxy appointments for the Annual General Meeting must be received by the Company’s Registrar, Computershare Investor Services PLC, no later than 2.00 pm (BST) on 19 September 2025.

Posting of Annual Report and AGM Notice

The Company confirms that the Annual Report and Accounts for the year ended 30 April 2025 and the Notice of the 2025 Annual General Meeting (‘AGM’) will be made available shortly to view or download by clicking the links below:

–  Ilika plc Notice of Annual General Meeting: https://www.ilika.com/investors/aim-rule-26

–  Ilika plc Annual Report and Accounts: 

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Search